INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,892,000 | +253.0% | 553,300 | +37.4% | 0.00% | – |
| Q2 2016 | $536,000 | -79.7% | 402,625 | -19.5% | 0.00% | -100.0% |
| Q1 2016 | $2,636,000 | -32.9% | 500,092 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $3,926,000 | -7.1% | 500,092 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $4,226,000 | +21.4% | 500,092 | +57.2% | 0.00% | 0.0% |
| Q2 2015 | $3,482,000 | -13.6% | 318,079 | +10.3% | 0.00% | 0.0% |
| Q1 2015 | $4,032,000 | -2.9% | 288,379 | +17.3% | 0.00% | 0.0% |
| Q4 2014 | $4,154,000 | -9.8% | 245,918 | -28.4% | 0.00% | 0.0% |
| Q3 2014 | $4,607,000 | -47.3% | 343,291 | -50.0% | 0.00% | 0.0% |
| Q2 2014 | $8,748,000 | +114.3% | 686,582 | +100.0% | 0.00% | 0.0% |
| Q1 2014 | $4,082,000 | -13.9% | 343,291 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $4,741,000 | -20.9% | 343,291 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $5,990,000 | +51.5% | 343,291 | +41.1% | 0.00% | +50.0% |
| Q2 2013 | $3,954,000 | +181.2% | 243,328 | +739.0% | 0.00% | +100.0% |
| Q1 2013 | $1,406,000 | – | 29,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
| EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
| ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |